Skip to main content
Fig. 3 | Cardiovascular Diabetology

Fig. 3

From: Combined effect of metformin with ascorbic acid versus acetyl salicylic acid on diabetes-related cardiovascular complication; a 12-month single blind multicenter randomized control trial

Fig. 3

Pattern of Framingham mean score and risks for diabetes related complications in the trial with ascorbic acid arm and acetylsalicylic acid arm versus control arm (n = 422). Control Arm (metformin + Placebo) n = 142, Parallel Arm I: metformin + Ascorbic acid 500 mg OD: n = 139, Parallel Arm II: metformin + acetylsalicylic acid 100 mg OD: n = 141, RDiaC: Risk for diabetes related complications, *p < 0.05, **p < 0.01 independent-samples t test: comparison between interventional arms (I & II) versus Control arm, ‡ p < 0.01 independent-samples t test: comparison Parallel arm I versus Parallel arm II

Back to article page